Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L P Ford

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Nucleic Acids Research|February 3, 1999
3'-Terminal RNA structures and poly(U) tracts inhibit initiation by a 3'-->5' exonuclease in vitroL P Ford, J Wilusz
Methods (San Diego, Calif.)|March 17, 1999
An in vitro system using HeLa cytoplasmic extracts that reproduces regulated mRNA stabilityL P Ford, J Wilusz
Molecular and Cellular Biology|January 1, 1997
The poly(A) tail inhibits the assembly of a 3'-to-5' exonuclease in an in vitro RNA stability systemL P Ford, P S Bagga, J Wilusz
Science'S STKE : Signal Transduction Knowledge Environment|December 26, 2001
An in vitro assay to study regulated mRNA stabilityD T Fritz, L P Ford, J Wilusz
RNA (New York, N.Y.)|August 11, 2001
The La antigen associates with the human telomerase ribonucleoprotein and influences telomere length in vivoL P Ford, J W Shay, W E Wright
Genes & Development|January 30, 1999
ELAV proteins stabilize deadenylated intermediates in a novel in vitro mRNA deadenylation/degradation systemL P Ford, J Watson, J D Keene, et al.
Molecular Cell|July 6, 2000
Interaction between a poly(A)-specific ribonuclease and the 5' cap influences mRNA deadenylation rates in vitroM Gao, D T Fritz, L P Ford, et al.
Nucleic Acids Research|May 11, 1995
The G-rich auxiliary downstream element has distinct sequence and position requirements and mediates efficient 3' end pre-mRNA processing through a trans-acting factorP S Bagga, L P Ford, F Chen, et al.
Molecular and Cellular Biology|November 14, 2000
Heterogeneous nuclear ribonucleoproteins C1 and C2 associate with the RNA component of human telomeraseL P Ford, J M Suh, W E Wright, et al.
Journal of Medical Systems|December 1, 1992
Evaluating productivity in clinical research programs: the National Cancer Institute's (NCI) Community Clinical Oncology Program (CCOP)D M Hynes, C P McLaughlin, A D Kaluzny, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Nucleic Acids Research|February 3, 1999
3'-Terminal RNA structures and poly(U) tracts inhibit initiation by a 3'-->5' exonuclease in vitroL P Ford, J Wilusz
Methods (San Diego, Calif.)|March 17, 1999
An in vitro system using HeLa cytoplasmic extracts that reproduces regulated mRNA stabilityL P Ford, J Wilusz
Molecular and Cellular Biology|January 1, 1997
The poly(A) tail inhibits the assembly of a 3'-to-5' exonuclease in an in vitro RNA stability systemL P Ford, P S Bagga, J Wilusz
Science'S STKE : Signal Transduction Knowledge Environment|December 26, 2001
An in vitro assay to study regulated mRNA stabilityD T Fritz, L P Ford, J Wilusz
RNA (New York, N.Y.)|August 11, 2001
The La antigen associates with the human telomerase ribonucleoprotein and influences telomere length in vivoL P Ford, J W Shay, W E Wright
Genes & Development|January 30, 1999
ELAV proteins stabilize deadenylated intermediates in a novel in vitro mRNA deadenylation/degradation systemL P Ford, J Watson, J D Keene, et al.
Molecular Cell|July 6, 2000
Interaction between a poly(A)-specific ribonuclease and the 5' cap influences mRNA deadenylation rates in vitroM Gao, D T Fritz, L P Ford, et al.
Nucleic Acids Research|May 11, 1995
The G-rich auxiliary downstream element has distinct sequence and position requirements and mediates efficient 3' end pre-mRNA processing through a trans-acting factorP S Bagga, L P Ford, F Chen, et al.
Molecular and Cellular Biology|November 14, 2000
Heterogeneous nuclear ribonucleoproteins C1 and C2 associate with the RNA component of human telomeraseL P Ford, J M Suh, W E Wright, et al.
Journal of Medical Systems|December 1, 1992
Evaluating productivity in clinical research programs: the National Cancer Institute's (NCI) Community Clinical Oncology Program (CCOP)D M Hynes, C P McLaughlin, A D Kaluzny, et al.
Pageof 2